NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Rutgers, The State University of New Jersey
Conditions: Coronavirus, SARS-CoV-2
Interventions: Non-Interventional
Countries: United States
Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease severity in a large healthcare system. We addressed this hypothesis by recruiting and longitudinally following 546 HCW and a comparison group of 283 non-HCW within a large academic health system, Rutgers Biomedical and Health Sciences (RBHS). By intensively following participants over a several year period (2020-2024) and collecting serial biospecimens (nasopharyngeal/throat swabs, blood, and saliva) and questionnaire data at multiple time points, we will uniquely characterize SARS-CoV-2 transmission and risk factors for COVID-19 among HCW and our larger academic community.
Sex: ALL
Age: 20 Years to —
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: * 20 years and older * Hospital and RBHS healthcare workers who have regular direct patient contact (≥3 patients/shift) in emergency rooms or inpatient settings that is expected to continue regularly over the next ≥3 months and who work ≥20 hours in the hospital weekly (residents, clinical fellows, attending physicians, nurse practitioners, physician assistants, registered nurses, license practice nurses, medical technicians, respiratory therapists, physical therapists, clinical pharmacists, dentists, dental hygienists, or dental assistants) * Hospital workers who do not have patient contact and non-healthcare from the Rutgers faculty, postdoctoral students, administrators, and staff. Exclusion Criteria: * Previous diagnosis with COVID-19 * Pregnant or have been diagnosed with a new medical condition in the past 30 days or have had a change in medications in the past 30 days * Participants who have been hospitalized in the past 30 days, had and had an emergency room, urgent care visit, or have had surgery. * Participants who have a fever on the day of their first visit to the study site (for consent, biospecimen collection, etc.).
- New Brunswick, New Jersey, United States
- New Brunswick, New Jersey, United States
- Newark, New Jersey, United States
- Newark, New Jersey, United States
- Newark, New Jersey, United States
- Piscataway, New Jersey, United States
- Piscataway, New Jersey, United States